Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys C Sagrinati, GS Netti, B Mazzinghi, E Lazzeri, F Liotta, F Frosali, ... Journal of the American Society of Nephrology 17 (9), 2443-2456, 2006 | 876 | 2006 |
Regeneration of glomerular podocytes by human renal progenitors E Ronconi, C Sagrinati, ML Angelotti, E Lazzeri, B Mazzinghi, L Ballerini, ... Journal of the American Society of Nephrology 20 (2), 322-332, 2009 | 611 | 2009 |
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign … M Gacci, G Corona, M Salvi, L Vignozzi, KT McVary, SA Kaplan, ... European urology 61 (5), 994-1003, 2012 | 460 | 2012 |
Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury ML Angelotti, E Ronconi, L Ballerini, A Peired, B Mazzinghi, C Sagrinati, ... Stem cells 30 (8), 1714-1725, 2012 | 389 | 2012 |
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia M Gacci, I Eardley, F Giuliano, D Hatzichristou, SA Kaplan, M Maggi, ... European urology 60 (4), 809-825, 2011 | 355 | 2011 |
Essential but differential role for CXCR4 and CXCR7 in the therapeutic homingof human renal progenitor cells B Mazzinghi, E Ronconi, E Lazzeri, C Sagrinati, L Ballerini, ML Angelotti, ... The Journal of experimental medicine 205 (2), 479-490, 2008 | 349 | 2008 |
EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) S Gravas, JN Cornu, M Gacci, C Gratzke, TRW Herrmann, C Mamoulakis, ... | 328* | 2020 |
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis M Gacci, G Corona, L Vignozzi, M Salvi, S Serni, C De Nunzio, A Tubaro, ... BJU international 115 (1), 24-31, 2015 | 296 | 2015 |
Characterization and functional role of androgen-dependent PDE5 activity in the bladder S Filippi, A Morelli, P Sandner, B Fibbi, R Mancina, M Marini, M Gacci, ... Endocrinology 148 (3), 1019-1029, 2007 | 271 | 2007 |
Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) S Gravas, T Bach, A Bachmann, M Drake, M Gacci, C Gratzke, ... European Association of Urology, 2015 | 225* | 2015 |
Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit L Vignozzi, A Morelli, E Sarchielli, P Comeglio, S Filippi, I Cellai, ... Journal of Endocrinology 212 (1), 71, 2012 | 218 | 2012 |
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation M Gacci, L Vignozzi, A Sebastianelli, M Salvi, C Giannessi, C De Nunzio, ... Prostate cancer and prostatic diseases 16 (1), 101-106, 2013 | 210 | 2013 |
Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders L Lasagni, L Ballerini, ML Angelotti, E Parente, C Sagrinati, B Mazzinghi, ... Stem cells 28 (9), 1674-1685, 2010 | 203 | 2010 |
Frequency of regulatory T cells in peripheral blood and in tumour‐infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma F Liotta, M Gacci, F Frosali, V Querci, G Vittori, A Lapini, V Santarlasci, ... BJU international 107 (9), 1500-1506, 2011 | 199 | 2011 |
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 M Gacci, M Coppi, E Baldi, A Sebastianelli, C Zaccaro, S Morselli, ... Human Reproduction 36 (6), 1520-1529, 2021 | 198 | 2021 |
Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats A Morelli, E Sarchielli, P Comeglio, S Filippi, R Mancina, M Gacci, ... The journal of sexual medicine 8 (10), 2746-2760, 2011 | 196 | 2011 |
Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation G Penna, B Fibbi, S Amuchastegui, C Cossetti, F Aquilano, G Laverny, ... The Journal of Immunology 182 (7), 4056-4064, 2009 | 195 | 2009 |
Benign prostatic hyperplasia: a new metabolic disease? L Vignozzi, G Rastrelli, G Corona, M Gacci, G Forti, M Maggi Journal of endocrinological investigation 37, 313-322, 2014 | 192 | 2014 |
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta‐analysis M Gacci, V Ficarra, A Sebastianelli, G Corona, S Serni, SF Shariat, ... The journal of sexual medicine 11 (6), 1554-1566, 2014 | 174 | 2014 |
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract B Fibbi, A Morelli, L Vignozzi, S Filippi, A Chavalmane, G De Vita, ... The journal of sexual medicine 7 (1_Part_1), 59-69, 2010 | 173 | 2010 |